| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $134.0M | +193.9% |
| Cost of Revenue | $5.7M | +419.2% |
| R&D Expense | $45.0M | -12.0% |
| SG&A Expense | $196.4M | +14.6% |
| Operating Income | -$111.5M | +38.3% |
| Pre-tax Income | -$106.4M | +41.0% |
| Income Tax | $1.8M | +140.5% |
| Net Income | -$108.2M | +40.2% |
| EPS (Basic) | -$0.76 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $94.1M | -59.4% |
| Accounts Receivable | $13.5M | -12.5% |
| Inventory | $24.8M | +28.1% |
| Current Assets | $442.5M | -13.8% |
| Total Assets | $470.9M | -13.3% |
| Current Liabilities | $46.1M | +13.4% |
| Total Liabilities | $65.4M | +1.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$79.5M | +49.6% |
| Investing Cash Flow | -$60.6M | +41.6% |
| Financing Cash Flow | $2.4M | -98.9% |
| +45.7% |
| EPS (Diluted) | -$0.76 | +45.7% |
| Stockholders' Equity |
| $405.4M |
| -15.4% |